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Abstract:  Ginkgolides are potent blockers of the glycine receptor Cl- channel (GlyR) pore.  We sought to 
identify their binding sites by comparing the effects of ginkgolides A, B and C and bilobalide on 
α1, α2, α1β and α2β GlyRs.  Bilobalide sensitivity was drastically reduced by incorporation of the β 
subunit.  In contrast, the sensitivities to ginkgolides B and C were enhanced by β subunit expression. 
However, ginkgolide A sensitivity was increased in the α2β GlyR relative to the α2 GlyR but not in the 
α1β GlyR relative to the α1 GlyR.  We hypothesised that the subunit-specific differences were mediated 
by residue differences at the second transmembrane domain 2’ and 6’ pore-lining positions.  The 
increased ginkgolide A sensitivity of the α2β GlyR was transferred to the α1β GlyR by the G2’A (α1 to 
α2 subunit) substitution. In addition, the α1 subunit T6’F mutation abolished inhibition by all 
ginkgolides.  As the ginkgolides share closely-related structures, their molecular interactions with pore-
lining residues were amenable to mutant cycle analysis.  This identified an interaction between the 
variable R2 position of the ginkgolides and the 2’ residues of both α1 and β subunits.  These findings 
provide strong evidence for ginkgolides binding at the 2’ pore-lining position. 
 
Running title: Glycine receptor ginkgolide binding 
 
Keywords: mutant cycle analysis, channel block, ligand-gated ion channel, Ginkgo biloba, patch clamp 
electrophysiology. 
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Extracts prepared from the leaves, roots and bark of the Ginkgo biloba tree are among the most 
widely used herbal medicines worldwide.  They have been used to treat a number of conditions including 
cerebrovascular and neurodegenerative disorders (Le Bars et al. 1997; Maclennan et al. 2002; Ahlemeyer 
and Krieglstein 2003). G. biloba extracts contain several terpene trilactone compounds that are believed 
to be the major active constituents.  The most abundant of these are ginkgolides A, B and C (GA, GB and 
GC) and bilobalide (BB) (van Beek 2005).  GB has long been known as a platelet activating factor 
antagonist (Sanchez-Crespo et al. 1985).  However, until recently there have been few insights into the 
molecular basis of the central nervous system effects of these compounds. 
GB was recently discovered to be a specific and potent pore blocker of the glycine receptor 
chloride channel (GlyR) with an IC50 of 0.27 µM (Kondratskaya et al. 2002).  Subsequent studies 
investigated the rank order of potency of ginkgolides and BB at the GlyR (Chatterjee et al. 2003; Ivic et 
al. 2003) and the GlyR subunit-dependence of GB inhibition (Kondratskaya et al. 2004).  A limitation of 
each of these studies is that they were performed on cultured hippocampal or cortical neurons where the 
GlyR subunit composition was unknown.  Nevertheless, these studies implicated GB as a subunit-
specific blocker of the GlyR, with a preference for β subunit-containing receptors.  This conclusion has 
recently been confirmed on homomeric α and heteromeric αβ GlyRs recombinantly expressed in 
Xenopus oocytes (Kondratskaya et al. 2005).  Interestingly, the earlier studies showed that GA was 
significantly less potent than GB or GC (Chatterjee et al. 2003; Ivic et al. 2003), despite the 3 
compounds sharing a highly conserved molecular structure (Fig. 1).   
GlyRs mediate inhibitory neurotransmission in the adult rat spinal cord and brainstem (Lynch 
2004).  They are anion-selective channels that belong to the pentameric cysteine-loop family of ligand-
gated ion channels (LGICs), of which the nicotinic acetylcholine receptor cation channel (nAChR) is the 
prototypical member.  To date, 5 GlyR subunits have been identified (α1-α4, β).  Embryonic receptors 
generally comprise α2 homomers or α2β heteromers, whereas the dominant adult subtype is the 
α1β heteromer (Lynch 2004).  Heteromeric GlyRs are believed to exist in a 2α:3β stoichiometry 
(Grudzinska et al. 2005), with the β subunit responsible for anchoring GlyRs to postsynaptic densities 
via the cytoplasmic protein, gephyrin (Kneussel and Betz 2000).  The α1, α2 and α3 subunits exhibit 
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differential synaptic distribution patterns that are particularly evident in the superficial dorsal horn of the 
spinal cord (Harvey et al. 2004) and in the retina (Haverkamp et al. 2003; Haverkamp et al. 2004).   The 
physiological consequences of the differential distribution patterns are difficult to establish as there are 
currently few pharmacological probes that can effectively discriminate among β subunit-containing GlyR 
isoforms (Lynch 2004). 
In an attempt to redress this situation and to understand the molecular basis of ginkgolide 
inhibition, the present study systematically investigated the specificity of GA, GB, GC and BB for 
recombinantly expressed α1, α2, α1β and α2β GlyRs.  Furthermore, because GA and GB exhibit 
significant differences in GlyR sensitivity despite differing in structure by only a single atom (Fig. 1), we 
reasoned that it might be possible to establish the molecular basis of the subunit specificity of these 
compounds.  Accordingly, the second aim of this study was to employ mutant cycle analysis to identify 
specific interactions between non-conserved GlyR pore-lining residues and structurally-divergent 
molecular groups of the ginkgolides.   
 
Materials and Methods 
 
Mutagenesis and expression of GlyR  cDNAs 
The human GlyR α1 subunit cDNA was subcloned into the pCIS2 plasmid vector.  The human α2 
subunit, which was kindly provided by Dr Paul Groot-Kormelink (University College, London), was 
subcloned into the pcDNA3.1 plasmid vector.  The human β subunit was subcloned into the pIRES2-
EGFP plasmid vector (Clontech, Palo Alto, CA, USA). Site-directed mutagenesis was performed using 
the QuickChange mutagenesis kit (Stratagene, La Jolla, CA, USA) and the successful incorporation of 
mutations was confirmed by sequencing the clones. HEK293 cells were transfected using a calcium 
phosphate precipitation protocol. When co-transfecting the GlyR α and β subunits, their respective 
cDNAs were combined in a ratio of 1:20. After exposure to transfection solution for 24 hrs, cells were 
washed twice using the culture medium and used for recording over the following 24 - 72 hrs. 
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Electrophysiology 
The cells were observed using a fluorescent microscope and currents were measured using the 
whole cell patch-clamp configuration. Cells were perfused by a control solution that contained (in mM): 
140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, with the pH adjusted to 7.4 with NaOH. 
Patch pipettes were fabricated from borosilicate hematocrit tubing (Vitrex, Modulohm, Denmark) and 
heat polished. Pipettes had a tip resistance of ~ 1.5 MΩ when filled with the standard pipette solution 
which contained (in mM): 145 CsCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 EGTA, with the pH adjusted to 
7.4 with NaOH. After establishment of the whole cell configuration, cells were voltage-clamped at –40 
mV (unless otherwise indicated) and membrane currents were recorded using an Axopatch 1D amplifier 
and pCLAMP9 software (Axon Instruments, Union City, CA, USA). The cells were perfused by a 
parallel array of microtubular barrels through which solutions were gravity-induced. All experiments 
were conducted at room temperature (19 – 22 oC).   
GFP fluorescence was used to identify cells expressing the GlyR β subunit.  The successful 
incorporation of β subunits into functional receptors was inferred by their characteristic reduction in 
picrotoxin sensitivity (Pribilla et al. 1992; Handford et al. 1996) as demonstrated in Table 2. 
GA, BB and picrotoxin (PTX) were obtained from Sigma (St Louis, MO, USA).  GB and GC were 
obtained from Biomol (Plymouth Meeting, PA, USA) and MP Biomedicals (Eschwege, Germany), 
respectively.  PTX was stored frozen as a 100 mM stock in dimethylsulfoxide.  Ginkgolides and BB were 
stored frozen as 10 mM stocks in dimethyl-sulfoxide. 
 
Data Analysis 
Results are expressed as mean ± standard error of the mean of 3 or more independent experiments. 
The Hill equation was used to calculate the saturating current magnitude (Imax), half-maximal 
concentration (EC50) and Hill coefficient (nH) values for glycine activation.  A similar equation was also 
used to calculate the half maximal concentrations for inhibition (IC50) and nH values of the antagonists 
tested in this study. All curves were fitted using a non-linear least squares algorithm (Sigmaplot 9.0, 
Jandel Scientific, San Rafael, CA, USA). Statistical significance was determined by paired or unpaired 
Student’s t-test, as appropriate, with P < 0.05 representing significance. 
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Homology modelling and compound docking 
LGIC subunits comprise a large extracellular N terminal domain followed and a cluster of 4 α-
helical transmembrane domains (M1-M4).  The residue at the putative intracellular boundary of the pore-
lining M2 domain is assigned position 1’, and the outermost residue of this domain is assigned 19’.  
SwissPDB viewer (Guex and Peitsch 1997) was used to build a model of the GlyR α1 subunit M1 and 
M2 domains by homology with the equivalent region of the nAChR α subunit in the electron 
microscopy-derived closed-channel structure (pdb code 1OED) (Miyazawa et al. 2003). The M1-M2 
loop was constructed from a loop database due to the presence of an extra residue relative to the 1OED 
template.  M1 was included in the model to constrain the M1-M2 loop.  As M1 does not directly line the 
pore, however, only the region from -2’ to 19’ of M2, including part of the M1-M2 loop, was assembled 
into a homopentameric model on the scaffold of the five M2 regions in 1OED.  Side-chain clashes were 
removed by energy minimisation. AutoDock 3.0 (Morris and Olsen 1998) was used to explore the 
possible interactions of ginkgolides with the central pore region of the model. The Lamarckian genetic 
algorithm was used to produce 100 conformations of each ligand, which were clustered within a root-
mean-squared deviation of 1.8 Å. Docked conformations of the ligands were inspected using VMD 
version 1.8 (Humphrey et al. 1996). 
 
Results 
 
Subunit-sensitivity of recombinant GlyRs to ginkgolides and BB 
This study compared the effects of extracellularly-applied GA, GB, GC, BB and PTX on 
recombinantly expressed α1, α2, α1β and α2β GlyRs.  The mean glycine Imax, EC50 and nH values for 
each of the 4 receptor subtypes are summarised in Table 1.    All values are within the range as measured 
previously for these receptors (Shan et al. 2001; Miller et al. 2004).  We then measured the steady-state 
inhibitory dose-response of each test compound at each receptor.   Compounds were applied at an EC50 
glycine concentration as determined empirically for each receptor subunit composition.  Examples of the 
inhibitory responses induced by 10 µM of each compound at each of the 4 receptor subtypes are shown 
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in Fig. 2A.  The averaged dose-responses for GA, GB, GC and BB are displayed in Fig 2B.  The 
averaged IC50 and nH values of best fit for these compounds and PTX are displayed in Table 1. 
The IC50 values for GA did not differ significantly among the α1, α2 and α1β GlyRs.  However, 
the GA sensitivity of the heteromeric α2β GlyR was significantly increased relative to the homomeric α1 
and α2 GlyRs (Table 2). 
The averaged dose-responses for GB and GC revealed a different pattern of subunit-dependence 
(Fig. 2B, Table 2).  The sensitivity of both compounds was significantly increased in the α1β heteromer 
relative to the α1 homomer and in the α2β heteromer relative to the α2 homomer (Table 2).  The 
homomeric α1 and α2 GlyRs were equally GC.  However, the α1 GlyR was slightly more sensitive than 
the α2 GlyR to GB, but this was not statistically significant.  Although Kondratskaya et. al. (2005) also 
found that β subunit incorporation increased GB potency, they found the α1 homomer to be significantly 
more sensitive than the α2 homomer to GB inhibition.  This difference may relate to the expression 
system: they used Xenopus oocytes whereas the present study was performed on HEK293 cells. 
The subunit-sensitivity of BB showed a dramatically different profile.  BB discriminated relatively 
weakly between the α1 and α2 homomeric GlyRs, although the α2 was significantly more sensitive to 
BB inhibition (Fig. 2B, Table 2).  Incorporation of the β subunit caused a drastic reduction in the BB 
sensitivities of both α1β and α2β GlyRs (Table 2).  The effects of PTX, which have already been 
characterised at these receptors (Pribilla et al. 1992; Lynch et al. 1995; Handford et al. 1996), are 
included as a control (Table 2).  We found the α2 homomer to be significantly more sensitive than the α1 
homomer to PTX inhibition.  However, as with BB, incorporation of the β subunit dramatically reduced 
the PTX sensitivity of both α1β and α2β GlyRs. Thus, BB and PTX exhibit qualitatively similar patterns 
of subunit-dependence. 
The above experiments quantitated the effects of extracellularly-applied ginkgolides.  We also 
sought to determine whether these compounds were active from the internal membrane surface.  With 30 
µM GA in the patch pipette, we found that the magnitude of whole-cell glycine-gated currents did not 
change significantly during the first 10 min of whole-cell recording (n = 3 cells, data not shown).  We 
therefore conclude that ginkgolides access their site from the extracellular surface only. 
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Functional properties of inhibition by ginkgolides and BB 
GB has previously been proposed as a pore-blocker of a native hippocampal neuron GlyR based on 
its glycine-independent, voltage-dependent and use-dependent properties (Kondratskaya et al. 2002).  
GC has also been shown to inhibit a native cortical neuronal GlyR in a use-dependent manner (Ivic et al. 
2003).  In the present study, we systematically investigated the voltage-dependence, glycine 
concentration-dependence and use-dependence of GA, GB, GC, BB and PTX at the α2 homomeric 
GlyR.  The α2 GlyR was chosen for analysis as the four G. biloba derivates showed approximately equal 
efficacy at this receptor (Table 2).  As a final test, we determined whether GA could be ‘trapped’ in the 
pore of the R271C GlyR in the closed state (Hawthorne and Lynch 2005).  
To investigate voltage dependence, we activated the GlyRs with an EC50 glycine concentration and 
compared the percentage inhibition induced by 10 µM of each compound at -40 and +40 mV.  Sample 
recordings (Fig. 3A) suggest that GA inhibition is voltage-dependent whereas BB inhibition is not.  The 
pooled results, summarised in Fig. 3B, reveal that inhibition by GA, GB and GC is significantly 
increased at depolarised potentials, whereas BB and PTX displayed no voltage-dependence.  We were 
unable to establish from the literature which of the G. biloba compounds are charged in a physiological 
saline at pH 7.4.   Assuming these compounds bind in the pore (see below), the voltage dependence of 
their inhibition implies that GA, GB and GC possess a net negative charge whereas picrotoxin and BB 
are uncharged.   
We then investigated the glycine concentration dependence of inhibition.  In this experiment, the 
inhibition induced by 10 µM of each compound was compared at an EC50 (50 µM) glycine concentration 
and a near-saturating (200 µM) glycine concentration.  Sample traces for GB and BB (Fig. 4A) suggest 
that GB inhibition is insensitive to glycine concentration, whereas BB inhibition decreases as glycine 
concentration is increased.  The pooled results, summarised in Fig. 4B, reveal that inhibition by GA, GB 
and GC is glycine-independent, whereas inhibition by BB and PTX is reduced as glycine concentration is 
increased. 
The use-dependence of the compounds was investigated as shown in Fig. 5A.  The left and right 
panels show the effects of 10 µM GA applied in the open and closed states, respectively.  As seen in the 
left panel, the rate of current recovery following GA removal is slower than the control rate of glycine-
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induced activation, due to the slow dissociation of GA.  If GA can access its site equally well in the open 
and closed states, the rate at which glycine activates the channels immediately after a closed state GA 
application should be slowed to a similar extent.  To facilitate comparison of glycine activation rates, 
single exponentials were fitted to the curves indicated by numbers 1, 2 and 3 with averaged time 
constants for GA, GB, GC and BB presented in Fig. 5B.  For all compounds tested, unbinding of the 
compound slowed glycine activation rate when applied in the open state but not when applied in the 
closed state.  These data demonstrate that when applied in the closed state, the compounds either do not 
reach the inhibitory site or bind with relatively low affinity.  Thus, all four compounds are use-dependent 
inhibitors of the α2 GlyR.  A similar analysis previously showed that PTX inhibition was not use-
dependent (Lynch et al. 1995). 
We recently showed that PTX and BB are ‘trapped’ in the pore of the α1R271C GlyR in the closed 
state (Hawthorne and Lynch 2005).  The α1R271C GlyR was employed as the effect is not apparent in the 
unmutated GlyR.  We reasoned that if GA is a pore blocker then it should exhibit similar trap behaviour.  
To investigate this, we activated the α1R271C GlyR with a 20 mM (saturating) concentration of glycine, 
then applied 10 mM GA in the open state, and determined its rate of unblock in the closed and open 
states.  Fig. 6A shows an example of the effect of applying GA in the continuous presence of glycine.  If 
glycine and GA are simultaneously removed once GA block has reached steady state, it is apparent that 
recovery from GA inhibition does not commence until glycine is re-applied 60 s later (Fig. 6B).  This 
indicates that GA is ‘trapped’ in the closed state.   When GA is applied in the closed state, a subsequent 
glycine application reveals that it does not reach its inhibitory site (Fig. 6C).  Similar results were 
recorded in each of 4 cells.  To quantitate these data, Fig. 6D shows the average percentage of original 
glycine current that was observed 65 s after the termination of the original glycine application under each 
of the experimental conditions depicted in Fig. 6A-C.  The 0 and 65 s time points are indicated in Fig. 
6A-C by the vertical dashed lines.  Fig. 6D shows that the only condition that results in significant block 
at the 65 s time point is when GA is trapped in the closed state for 60 s. 
In agreement with previous reports (Kondratskaya et al. 2002; Ivic et al. 2003), the results of these 
functional assays provide a strong case for ginkgolides binding in the pore.  Because BB inhibition 
decreases as glycine concentration increases, it cannot be regarded as a classical pore blocker.   
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Molecular determinants of ginkgolide inhibition 
Several studies have shown that the PTX sensitivity of anionic LGICs is sensitive to mutations at 
the 2’ and 6’ pore-lining positions (Ffrench-Constant et al. 1993; Gurley et al. 1995; Wang et al. 1995; 
Xu et al. 1995; Zhang et al. 1995; Etter et al. 1999; Shan et al. 2001).  We previously demonstrated that 
the GlyR α1 ? β subunit mutation, G2’P, significantly increased the PTX sensitivity of homomeric α1 
GlyRs (Shan et al. 2001).  We have also shown that the α1 ? β subunit substitution, T6’F, drastically 
reduced the sensitivity of homomeric α1 GlyRs to both PTX and BB (Shan et al. 2001; Hawthorne and 
Lynch 2005).  Given these findings, we hypothesized that ginkgolides inhibit GlyRs by blocking the 
channel in the 2’ - 6’ region and that subunit-specific differences in sensitivity are most likely due to 
residue differences at these positions. 
A sequence alignment of the α1, α2 and β subunit M2 domains is shown in Fig. 7A, highlighting 
the differences at the 2’ and 6’ positions. As the minimum diameter of a GlyR open channel is about 6 Å 
(Fatima-Shad and Barry 1993; O'Mara et al. 2005) and structural data for the nAChR channel suggest a 
similar diameter at the 2’ position (Miyazawa et al. 2003), it is not clear whether it is feasible for 
ginkgolides, with a minimum diameter of 8.9 Å (Zhao et al. 2002), to access this position in the channel 
pore. To examine the feasibility of this blocking site, we built a model of the pentameric α1 GlyR M2 
region and part of the M1-M2 loop by homology with the nAChR channel structure (Miyazawa et al. 
2003).  We then used in-silico docking to investigate the possibility of ginkgolides binding within the 
pore.  
The docking results indicated that ginkgolide binding was possible at a number of sites in the pore 
but, based on lowest estimated energy and greatest clustering of docks, by far the best site was adjacent 
to the 2’ and 6’ positions, as shown for GA in Fig. 7B. Other possible sites indicated by docking were 
mostly near the extracellular mouth of the channel.  Interestingly, no docking sites were found near the 
conserved L9’ residue at the pore midpoint. This is consistent with a narrow constriction at the 9’ 
position that is too narrow to accommodate a ginkgolide.  This constriction presumably restricts access to 
and from the 2’-6’ positions in the closed state.  Although our model is based on a closed state 
conformation, the conformational changes associated with channel opening in the nAChR appear 
relatively subtle in this region (Unwin 1995). Consequently, our data support the feasibility of 
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ginkgolides blocking the open GlyR pore at the 2’- 6’ region. Given the uncertainties of our GlyR model, 
especially in our use of a loop database to model the M1-M2 loop, we have not attempted to use docking 
to predict specific interactions between ginkgolides and the channel-lining groups. Rather we have used 
site-directed mutagenesis of the 2’ and 6’ residues to further investigate such potential interactions. 
As the α1 subunit T6’F mutation drastically reduced the potency of both PTX and BB (Hawthorne 
and Lynch 2005), we hypothesised it should have a similar effect on the sensitivity to GA, GB and GC.  
Indeed, as shown in Fig. 7C, the sensitivity to all 3 ginkgolides was abolished in the α1T6’F GlyR.  Thus, 
a ring of 5 phenylalanines at the 6’ pore-lining position dramatically disrupts inhibition by ginkgolides, 
BB and PTX.  However, as ginkgolide sensitivity is actually increased in the presence of the β subunit 
(Table 2), it appears that any negative effect of the 6’ phenylalanines must be minor provided that they 
are restricted to the β subunit in αβ heteromers.  Moreover, despite the α1β and α2β GlyRs having no 
variation in structure at the 6’ position, the ginkgolides display significant differences in sensitivity 
between these receptors (Table 2). These observations suggest that ginkgolide specificity is dominated 
by other subunit-specific differences, with the 2’ residues being obvious candidates.  These experiments 
rule out the possibility that the β subunit F6’ may be a binding site.  However, it remains possible that 
the α subunit T6’ residues could contribute to ginkgolide coordination.   
Since the wild type (WT) homomeric α1 and α2 GlyRs exhibit similar sensitivities to all 3 
ginkgolides (Table 2), it is unlikely that the G2’A (α1 ? α2 subunit) substitution will significantly affect 
the ginkgolide sensitivity of homomeric α1 GlyRs.  We have previously shown that this mutation has no 
effect on glycine sensitivity (Table 1).  As anticipated, the homomeric α1, α2 and α1G2’A GlyRs all 
exhibited similar GA sensitivities (Fig. 7D, left panel).  The mean IC50 and nH values for GA at the 
α1G2’A GlyR were 3.0 ± 0.6 µM and -0.9 ± 0.1 (both n = 4), respectively.  These values did not differ 
significantly from their respective values at the α1 GlyR.  However, we demonstrated above that 
incorporation of the β subunit increased GA sensitivity in the α2β GlyR but not in the α1β GlyR (Table 
2).  This prompts the hypothesis that the G2’A substitution may increase GA sensitivity in α1G2’Aβ 
heteromers relative to the α1β heteromers.  Fig. 7D (right panel) shows the averaged dose-response for 
GA at the heteromeric α1G2’Aβ GlyR.  The mean IC50 and nH values were 1.4 ± 0.3 µM and -1.0 ± 0.1 
(both n = 4), respectively.  The mean IC50 was significantly lower than the mean α1β GlyR value (P < 
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0.01) but not significantly different to the mean α2β GlyR value.  Thus, the increased GA sensitivity of 
the α2β GlyR over the α1β GlyR is mediated by the G2’A (α1 ? α2 subunit) substitution.  A recent 
study showed that the α1 subunit G2’A mutation reduced GB sensitivity to the level seen in the α2 GlyR 
(Kondratskaya et al., 2005).   
As noted above, introduction of the β subunit increases the potency of GB and GC (Table 2).  As 
this effect is independent of which α subunit is present, we hypothesised it was due to the introduction of 
the β subunit prolines at the 2’ position.  If so, the effect might be mimicked by introducing the G2’P (α1 
? β) mutation into the homomeric α1 GlyR.  We have previously shown that this mutation increases the 
glycine EC50 value to around 150 µM (Table 1).  Averaged dose-responses for GA, GB, GC and BB at 
the α1G2’P GlyR, measured in the presence of an EC50 glycine concentration, are displayed in Fig. 8 and 
the averaged parameters of best fit are presented in Table 2.  The corresponding dose-response curves at 
the WT α1 GlyR, reproduced from Fig. 2, are included in Fig. 8 as dashed lines.  These results show that 
the G2’P mutation caused modest, but significant, increases in sensitivity to BB and GC, but dramatic 
decreases in sensitivity to GA and GB. 
Clearly, the G2’P mutation in the α1 homomer does not replicate the effect on ginkgolide 
sensitivity of adding the β subunit. There does, however, appear to be a trend whereby the presence of 
prolines at the 2’ position improves the relative affinity for GC over GB and for GB over GA.  To 
investigate further the role of the 2’ residues in determining ginkgolide sensitivity, we compared the 
potencies of GA, GB and GC on WT α1β GlyRs with their effects on the α1βP2’G, α1G2’Pβ, and 
α1G2’PβP2’G mutant GlyRs.  The results of these experiments are summarised in Table 3.   Note that in 
some cases, receptor sensitivity to ginkgolides was so low that IC50 values could not be measured. These 
data indicate that the affinity for ginkgolides is not determined simply by the number of 2’P residues but 
the apparent trend of 2’P residues improving the relative affinity for GC over GB over GA does seem to 
be maintained. As GA, GB and GC are identical except for the presence, respectively, of 0, 1 or 2 
hydroxyl groups at the R1 and R2 positions (Fig. 1), the effect of 2’ mutations on relative ginkgolide 
affinity hints at a direct interaction with this residue. To further examine the evidence for such an 
interaction, we applied double-mutant cycle analysis to our data. 
 
  17/01/2006 
 13
  17/01/2006 
 14
Mutant cycle analysis 
Mutant cycle analysis has been widely used to investigate interactions between pairs of residues in 
proteins (Hidalgo and MacKinnon 1995; Schreiber and Fersht 1995; French and Dudley 1999) or 
between protein residues and molecular groups on non-peptide ligands (Penzotti et al. 2001; Yan and 
White 2005).  In the latter case, the effect on ligand affinity of changing a ligand group or a protein 
residue, either individually or both together, is measured. If the individual effects are independent and 
additive, indicating no effective interaction between the two groups, then the coupling coefficient (Ω), 
defined in eq. 1 below, will be equal to one.   
 
Ω =  (IC50WT, L1).(IC50MUT, L2) 
         ___________________ 
         (IC50WT, L2).(IC50MUT, L1)         (eq. 1) 
 
The subscripts WT and MUT represent the wild type and mutant receptor, respectively, and L1 and 
L2 denote the two ligands being compared. Note that ligand affinities rather than IC50s are normally used 
in this equation.  However, we assume that these two quantities are equivalent for non-competitive 
antagonists such as ginkgolides.  Values of Ω > 2.5 have been shown to identify direct interactions 
between molecular groups (Schreiber and Fersht 1995).  The interaction energy, ∆∆Gint, between the two 
substituted groups is given by RTlnΩ, where R is the gas constant and T is temperature. 
  GA and GB differ in structure by a single group at position R1, with a hydrogen in GA replaced 
by a hydroxyl in GB (Fig. 1).  Similarly, GC differs from GB by substitution of a hydrogen with a 
hydroxyl at position R2 (Fig. 1). Consequently, double-mutant cycle analysis of the IC50s for GB versus 
GA or GC versus GB at WT versus 2’ mutant GlyRs reports on possible interactions between the 2’ 
residue and the R1 or R2 positions, respectively. Fig. 9 shows the mutant cycles that we analysed, with Ω 
values and interaction energies in the centre of each cycle. The arrows indicate the starting and finishing 
point for each cycle. For ease of comparison, we have defined receptors with all glycines at 2’ as the 
starting point for each cycle so effectively a G ? P substitution is always considered. Likewise, GC is 
used as L1 (starting point) relative to GB as L2 and GB as L1 relative to GA as L2.  Thus removal of a 
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hydroxyl is always tested. Note that not all of the IC50 data could be included in mutant cycle analysis as 
some cycles could not be completed due to an incomplete data set.  
As shown in Fig. 9, mutant cycle analysis provides evidence for an interaction between the 
ginkgolide R1 position and the 2’ position in α1 homomers (Fig. 9A, cycle 2) but the interaction energy 
is relatively weak and there is no evidence for such an interaction in α1β heteromers. Much more 
convincing is the consistent evidence for a stronger interaction between the ginkgolide R2 position and 
the GlyR 2’ position in both α1 homomers (Fig. 9A, cycle 1) and α1β heteromers (Fig. 9B).  This occurs 
regardless of whether the 2’ substitution is in the α1  subunit (cycle 5) or β subunit (cycle 3). In all cases, 
a G2’P substitution improves the relative affinity for GC over GB, indicating a positive interaction 
between the R2 hydroxyl in GC and a 2’P that is not present with a 2’G. This provides strong supporting 
evidence that the ginkgolide-binding site is adjacent to the 2’ position in the GlyR open pore. 
 
Discussion 
 
Subunit-sensitivity of inhibition by ginkgolides and BB 
This study has demonstrated that GA, GB and GC are subunit-selective inhibitors of recombinant 
GlyRs. There was no significant difference in sensitivity between α1 and α2 homomeric GlyRs to any of 
the three compounds.  However, both the α1β and α2β GlyRs show a significantly increased sensitivity 
to GB and GC, relative to their respective homomers.  On the other hand, GA sensitivity is increased in 
the α2β GlyR relative to the α2 GlyR but not in the α1β GlyR relative to the α1 GlyR.   Thus, together 
these compounds are able to distinguish α1 from α2 subunit-containing αβ GlyRs and can discern the 
presence of the β subunit.  Ginkgolides may therefore be useful as pharmacological probes for 
identifying the subunit composition of synaptic GlyRs. 
These results are largely consistent with previous results from native GlyRs expressed in cultured 
hippocampal neurons. Hippocampal GlyRs showed an age-dependent increase in GB sensitivity that 
coincided with a decreased PTX sensitivity (Kondratskaya et al. 2004).  This strongly suggests that the 
increased GB sensitivity was mediated by a switch in GlyR stoichiometry from α homomeric to αβ 
heteromeric. Adult hippocampal neuronal GlyRs, which are most likely α1β heteromers (Lynch 2004), 
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showed a relatively high sensitivity to GB and GC but a lower sensitivity to GA (Chatterjee et al. 2003).  
However, a significant point of difference is that the adult hippocampal GlyRs were 5 – 10 times more 
ginkgolide-sensitive (Kondratskaya et al. 2002; Chatterjee et al. 2003; Kondratskaya et al. 2004) than the 
recombinant α1β GlyRs examined here. The basis for this difference is not yet known.  A report 
published after completion of this study found that the GB sensitivity of GlyRs recombinantly expressed 
in Xenopus oocytes is also increased in the presence of the β subunit (Kondratskaya et al. 2005).   
The subunit-selectivity of BB inhibition of the GlyR has not previously been investigated.  This 
study reveals BB to be modestly selective for homomeric α2 GlyRs over α1 GlyRs, but highly selective 
for α homomers over αβ heteromers. The inhibitory properties of GA, GB, GC and BB have recently 
been investigated at recombinantly-expressed α1β2γ2L GABAARs (Huang et al. 2003; Huang et al. 
2004).  BB was the most potent of these compounds with an IC50 value near 5 µM. similar to the GlyR, 
ginkgolides inhibited the α1β2γ2L GABAAR in a manner that was non-competitive with agonist.  On the 
other hand, BB inhibition displayed elements of both competitive and non-competitive antagonism 
(Huang et al. 2003).   
   
Molecular determinants of ginkgolide inhibition 
The functional properties of ginkgolide inhibition, summarised in Figs. 3-6, suggest a binding site 
deep within the open channel pore. Our modelling and docking results support the feasibility of a binding 
site in the pore adjacent to the 2’ and 6’ positions, a location that is strongly supported by our site-
directed mutagenesis data.  We show that the α1T6’F mutation abolishes ginkgolide sensitivity and that a 
Gly for Ala substitution at the 2’ position is responsible for the differential GA sensitivity of α1β and 
α2β GlyRs. Further strong support for a binding site adjacent to the 2’ position comes from mutant cycle 
analysis of the relative sensitivity to GA, GB and GC of α1 and α1β GlyRs. This analysis revealed a 
significant interaction between the ginkgolide R2 position and the 2’ residues in α1 homomers and in 
both α1 and β subunits of α1β heteromers (Fig. 9). In all cases this interaction was positive with a 
hydroxyl at the R2 position and proline at the 2’ position.  
Substitution of proline by glycine is non-conservative.  Nevertheless, we rule out the idea that 
proline causes a non-specific structural change in the pore as this would not be expected to discriminate 
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between large molecules that differ in structure by a single atom.  Apart from removing a bulky side-
chain, the P2’G substitution may affect backbone conformation. Consequently, it is difficult to predict 
the nature of interactions disrupted by such substitutions.  Nevertheless, several considerations are 
worthy of discussion. The magnitudes of the calculated interaction energies (Fig. 9) suggest the existence 
of van der Waals interactions between the R2 hydroxyl and the 2’P side-chain. Alternatively, the R2 
hydroxyl could contribute to a hydrogen bond but no hydrogen bonds are available directly with a 
proline side-chain. Hydrogen bonds with the channel near the 2’ position may, however, be indirectly 
disrupted by a P2’G substitution.  Firstly, the 2’ backbone nitrogen would become available as a 
hydrogen bond donor, and this may interact with a hydrogen bond acceptor on a side-chain located more 
cytoplasmic than the 2’ position. Thus, if this putative acceptor interacts with the backbone nitrogen of a 
2’G, substitution with a 2’P may make the acceptor available to interact with the R2 hydroxyl of GC, 
potentially explaining the mutant cycle results. This putative interaction with R2 is highly speculative 
because our GlyR channel model becomes less reliable around the cytoplasmic end of the pore due to the 
presence of extra residues relative to the nAChR template.  Thus, the identity of the putative hydrogen 
bond acceptor cannot be predicted with any certainty. A second possibility is that P2’G substitutions may 
induce local conformational changes that reduce the availability of other hydrogen bonding side-chains, 
such as T6’ residues, consistent with our T6’F mutant results.  
Our mutant cycle analysis provides strong evidence for ginkgolides binding at the 2’ position of 
the GlyR channel but it is beyond the limits of our current data and the accuracy of our channel model to 
predict the precise positioning and orientation of the bound ginkgolides. In a recent study, systematic 
modification of the hydroxyl groups on GC showed that all four hydroxyl groups on this compound are 
important for its inhibition of GlyRs (Jaracz et al. 2004). This provides further support for the role of 
hydroxyl groups in GC binding, emphasizes a probable role for hydrogen bonds and offers further 
opportunities for defining the binding interactions by mutant cycle analysis.  
 
Molecular mechanism of BB inhibition 
On the basis of its use-dependence, closed state trap and sensitivity to the T6’F mutation, we 
previously inferred that BB binds in the α1 GlyR pore (Hawthorne and Lynch 2005).  We show here that 
incorporation of the β subunit increased GlyR sensitivity to ginkgolides but decreased GlyR sensitivity to 
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BB, implying substantial differences in their respective binding mechanisms. The present study has also 
shown that BB inhibition is similar to ginkgolide inhibition in that it is use-dependent.  However, unlike 
the ginkgolides, BB inhibition is voltage-independent and shows competition with glycine.  It will be 
interesting to establish the structural basis of these differences.  Elucidation of the molecular basis of BB 
inhibition may provide insights into the pore structural rearrangements that accompany GlyR activation.   
  
Summary 
We have identified GA, GB, GC and BB as subunit-selective inhibitors of the GlyR.   Using 
mutant cycle analysis we have provided strong evidence that ginkgolides bind in the pore at the level of 
the 2’ pore-lining residues.  The subunit-selectivity of ginkgolides can be partially explained by subunit-
specific differences in amino acids at the 2’ pore-lining position.  Future experiments aimed at more 
precisely delineating the binding sites of ginkgolides and BB may place constraints on the pore 
conformation and side-chain exposure in the closed and open states. 
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Figure legends 
 
Figure 1.  Structures of GA, GB, GC and BB. 
 
Figure 2.  Effects of ginkgolides, BB and PTX on α1, α2, α1β and α2β GlyRs.  A.  Sample currents 
recorded in response to 10 µM concentrations of the indicated compounds.  All traces in each row 
were recorded from cells expressing the subunits as indicated on the left.  Peak current magnitudes in 
displayed traces ranged from 0.7 - 5 nA.  Each current trace is 15 s long.  An inward (downward) 
current was activated by an EC50 glycine concentration at around the 2 s mark and this was terminated 
at 12 s (as indicated by unfilled bar in top left trace), with the test compound being added for a 3-5 s 
period once the glycine response reached steady-state (filled bar in top left trace).  Unless otherwise 
indicated, all current traces in subsequent figures conform to this protocol.  B.    Averaged 
concentration-response curves for GA, GB, GC, BB and PTX.  In each of the 5 panels, the α1 GlyR is 
represented by filled circles, the α2 GlyR by unfilled circles, the α1β GlyR by filled triangles and the 
α2β GlyR by unfilled triangles.  At least 4 full concentration-response relationships were averaged for 
each compound at each receptor.  Averaged IC50 and nH values are summarised in Table 2. 
 
Figure 3.  Voltage-dependence of inhibition in the α2 GlyR.  A.  Sample traces recorded at -40 and 
+40 mV in the presence of EC50 glycine plus either 10 µM GA (left panel) or 10 µM BB (right panel).   
B.  Averaged percentage inhibition induced by each of the indicated compounds at -40 and +40 mV.  
Each bar represents the average of 3-5 cells. 
 
Figure 4.  Glycine concentration-dependence of inhibition in the α2 GlyR.  A.  Effects of 10 µM GB 
(left panel) and 10 µM BB (right panel) in the presence of 50 µM (~EC50) glycine and 200 µM 
(~EC100) glycine.   B.  Averaged percentage inhibition induced by each of the indicated compounds in 
the presence of 50 and 200 µM glycine.  Each bar represents the average of 3-5 cells. 
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Figure 5.  Use-dependence of inhibition in the α2 GlyR. A.  The left panel shows a control where 10 
µM GA is applied in the presence of 50 µM glycine.  The right panel, from the same cell, shows the 
effect of a 5 s pre-exposure to 10 µM GA followed immediately by a 50 µM application of glycine.  
The ‘activation’ curves, labelled 1, 2 and 3, were fitted with single exponentials.  Time constants for 
curves 2 and 3 were normalised to the curve 1 value.  B.    Activation time constants for each 
compound averaged from 4 cells are shown normalised relative to the curve 1 value.  All compounds 
significantly inhibited the glycine activation rate when applied in the open state, but not when applied 
in the closed state. 
 
Figure 6.   GA trap in the α1R271C GlyR.  A.  All data in A-C were from the same cell.  Glycine was 
applied throughout at 20 mM and GA at 10 µM.  Glycine was applied as shown by the unfilled bar, 
and GA by the filled bar.  Note slow recovery from GA inhibition.  B.  Similar experiment to A except 
that glycine and GA were simultaneously removed once GA inhibition reached steady-state.  Glycine 
was reapplied 60 s later revealing GA trap.  C.  GA applied in the closed state does not result in 
significant trap.  D.  The mean current amplitude at the 65 s time point is expressed as a percentage of 
peak control current magnitude for the 3 experimental conditions depicted in panels A-C.  The 0 and 
65 s time points are shown by the vertical dashed lines.  All experiments were averaged from 4 cells, 
and only experiment B resulted in a significant (P < 0.05) current decrease at 65 s.   
 
Figure 7.  Modulation of ginkgolide sensitivity by mutations at the 2’ and 6’ pore-lining positions.  A.  
Sequence alignment of the α1, α2 and β GlyR subunit M2 domains.  Residues at the 2’ and 6’ 
positions that were mutated in this study are shown in bold.  The α1 and α2 subunit sequences differ 
by a single residue at the 2’ position, whereas α and β subunit sequences are poorly conserved.  B. 
Pentameric model of the M2 region of the homomeric α1 GlyR, with the backbone shown as ribbons 
and the G2’ and T6’ residues shown as sticks, coloured by atom. The extracellular pore surface is at 
the top.  The best cluster for docking of GA into this structure is shown in gold. C.  Sensitivity to all 3 
tested ginkgolides was abolished in the homomeric α1T6’F GlyR.  All results representative of 4 cells.  
Ginkgolides were applied at 30 µM and glycine was applied at 50 µM. Note that elimination of 
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inhibition uncovered a consistent potentiation that may represent a very weak, low efficacy agonist 
effect at some other site.   D.  Differential sensitivity of α1β and α2β GlyRs to GA is due to the G2’A 
substitution.  The left panel shows averaged GA dose-response curves in the α1G2’A GlyR, with the 
corresponding curves for the α1 and α2 GlyRs included as dashed lines for comparison.  The right 
panel shows averaged GA dose-response curves in the α1G2’Aβ GlyR, with the corresponding curves 
for the α1β and α2β GlyRs included as dashed lines. 
 
Figure 8.    Ginkgolide sensitivity changes mediated by the α1 subunit G2’P mutation.  Averaged 
dose-responses of GA, GB, GC and BB in the homomeric α1G2’P GlyR.  Corresponding values for the 
WT α1 GlyR are shown as dashed lines for comparison.  Curve parameters of best fit are summarised 
in Table 2. 
 
Figure 9.  Mutant cycle analysis reveals interactions between ginkgolides and the 2’ residues of 
homomeric α1 and heteromeric α1β GlyRs.  Mutant cycle analysis of the interaction of GA, GB and 
GC with: A. WT and G2’P mutant homomeric α1 GlyRs and B. heteromeric WT α1β and α1βP2’G and 
α1G2’PβP2’G heteromeric GlyRs.  The Ω values (calculated as in Eq. 1) are shown at the centre of each 
cycle together with the calculated ∆∆Gint. Errors in these values were determined by standard 
propagation of errors using the geometric sum of the relative errors for each IC50 value. 
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Table 1.  Functional properties of GlyRs used in this study. 
 
GlyR Imax 
(nA) 
EC50  
(µM) 
nH n 
α1 4.8 ± 0.8 34.6 ± 1.8 2.0 ± 0.2 9 
α2 4.0 ± 1.2 73 ± 6** 1.6 ± 0.2 9 
α1β 3.6 ± 0.9 40.3 ± 6.3 1.6 ± 0.2 9 
α2β 5.1 ± 1.3 68 ± 4** 2.0 ± 0.2 4 
α1T6'F # 0.63 ± 0.05 6.4 ± 1.1* 1.5 ± 0.1 6 
α1G2'A # 3.7 ± 0.8 33 ± 1 3.5 ± 0.3 4 
α1G2'P # 2.9 ± 0.3 147 ± 27** 2.5 ± 0.3 5 
α1βP2'G # 4.1 ± 1.2 24 ± 3 2.5 ± 0.2 4 
α1R271C @ 8.2 ± 2.2 3350 ± 310*** 1.8 ± 0.3 12 
*** P < 0.001 using Student’s unpaired t-test. 
# Results reproduced from Shan et al. (2001) and @ Lynch et al. (2001). 
 
 
 
 
 Table 2.  IC50 and nH values for ginkgolides, BB and PTX at WT GlyRs and the homomeric αG2’P GlyR. 
*P < 0.05, ** P < 0.01, *** P < 0.001 relative to the corresponding value at the α1 GlyR using Student’s unpaired t-test. 
#P < 0.05, ## P < 0.01, ### P < 0.001 relative to the corresponding value for GA at the same GlyR using Student’s unpaired t-test. 
@  Reproduced from Shan et al., 2001 
 
 
α1 
 
α2 
 
α1β 
 
α2β 
 
α1G2’P 
compound 
IC50 (µM) nH IC50 (µM) nH IC50 (µM) nH IC50 (µM) nH IC50 (µM) nH 
GA 5.9 ± 1.7 -0.87 ± 0.06 11.9 ± 2.9 -0.59 ± 0.07* 9.6 ± 1.4 -0.49 ± 0.07* 1.2 ± 0.4* -0.93 ± 0.15 183 ± 27** -0.74 ± 0.04 
GB 7.9 ± 1.8 -0.85 ± 0.07 11.4 ± 2.9 -0.61 ± 0.07* 2.5 ± 0.8 *## -0.52 ± 0.05 ** 0.8 ± 0.3 *** -0.79 ± 0.15 49 ± 13*# -0.50 ± 0.09 *# 
GC 10.5 ± 0.8# -0.97 ± 0.06 10.0 ± 2.2 -1.00 ± 0.27 1.5 ± 0.3***### -0.64 ± 0.08 ** 0.40 ± 0.09 *** -0.62 ± 0.05** 4.3 ± 0.6**## -0.59 ± 0.08 * 
BB 19.6 ± 1.6## -0.58 ± 0.06# 7.7 ± 2.0** -0.58 ± 0.08 204 ± 55* -0.53 ± 0.13 44.9 ± 7.3 *### -0.83 ± 0.11 11.9 ± 2.9*### -0.85 ± 0.11* 
PTX 6.3 ± 0.7 -0.95 ± 0.19 2.3 ± 1.0*## -0.61 ± 0.08 219 ± 28 ***## -0.56 ± 0.05 29.7 ± 2.6***### -1.31 ± 0.22 2.6 ± 0.6*###@ -0.90 ± 0.05@ 
 Table 3.  IC50 and nH values for GA and GB at GlyRs incorporating mutations at the 2’ position. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asterisks represent significance using unpaired Student’s t-test relative to the α1G2’P GlyR values. * P < 0.05, ** P < 0.01, *** P < 0.001 
 
  
 
α1G2’P α1G2’Pβ α1G2’PβP2'G α1βP2’G 
compound 
IC50 (µM) nH IC50 (µM) nH IC50 (µM) nH IC50 (µM) nH 
GA 183 ± 27 -0.74 ± 0.04 > 300  > 300  7.1 ± 3.9 *** -1.00 ± 0.48 
GB 49 ± 13 -0.50 ± 0.09  116 ± 23* -0.81 ± 0.07 162 ± 8*** -0.78 ± 0.05 0.81 ± 0.11* -0.91 ± 0.14 
GC 4.3 ± 0.6 -0.59 ± 0.08 > 300  69 ± 25* -0.53 ± 0.10 4.3 ± 1.8 -0.56 ± .07 
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